Korean J Anesthesiol.  1993 Jun;26(3):576-580. 10.4097/kjae.1993.26.3.576.

A Case Report of Malignant Hyperthermia during Anesthesia

Affiliations
  • 1Department of Anesthesiology, College of Medicine, InJe University Paik Hospital, Korea.

Abstract

Malignant hyperthermia is a potentially fatal hypermetabolic syndrome characterised by hyperpyrexia and skeletal muscle rigidity. It can be induced by all of the currently used inhalation anesthetics or by injection of succinylcholine. A case of malignant hyperthermia was experienced which developed 80 minute after induction of general anesthesia with thiopental sodium, suecinylcholine, halothane, N2O and O2. One and half hours after induction, arrhythmia developed and was followed by unstable blood pressure, hyperpyrexia and muscle rigidity. Anesthesia was terminated and vigorous emergency treatment and dantrolene were administered. The patient recovered normal body temperature and consciousness, but expired about 4 days after induction because of late complication including disseminated intravascular coaggulation. The etiologic factor, clinieal feature, treatment and prevention of Malignant hyperthermia are discussed.

Keyword

Malignant hyperthermia; Halothane; Succinylcholine; Dantrolene

MeSH Terms

Anesthesia*
Anesthesia, General
Anesthetics, Inhalation
Arrhythmias, Cardiac
Blood Pressure
Body Temperature
Consciousness
Dantrolene
Emergency Treatment
Halothane
Humans
Malignant Hyperthermia*
Muscle Rigidity
Muscle, Skeletal
Succinylcholine
Thiopental
Anesthetics, Inhalation
Dantrolene
Halothane
Succinylcholine
Thiopental
Full Text Links
  • KJAE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr